Nuclear Medicine Market
Industry: Healthcare
Published Date: August-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 180
Report ID: PMRREP34724
1. Executive Summary
1.1. Global Nuclear Medicine Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Epidemiology - Disease Prevalence and Incidence
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Global Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Nuclear Medicine Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2018 - 2022
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
4.3.3.1. Diagnosis
4.3.3.2. SPECT
4.3.3.3. PET
4.4. Market Attractiveness Analysis: Product
4.5. Global Nuclear Medicine Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2018 - 2022
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
4.5.3.1. Urology
4.5.3.2. Cardiology
4.5.3.3. Neurology
4.6. Market Attractiveness Analysis: Application
4.7. Global Nuclear Medicine Market Outlook: End Use
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2018 - 2022
4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
4.7.3.1. Hospitals
4.7.3.2. Diagnostic Centres
4.8. Market Attractiveness Analysis: End Use
5. Global Nuclear Medicine Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
6.2.1. By Country
6.2.2. By Product
6.2.3. By Application
6.2.4. By End Use
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
6.4.1. Diagnosis
6.4.2. SPECT
6.4.3. PET
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
6.5.1. Urology
6.5.2. Cardiology
6.5.3. Neurology
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
6.6.1. Hospitals
6.6.2. Diagnostic Centres
6.7. Market Attractiveness Analysis
7. Europe Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
7.2.1. By Country
7.2.2. By Product
7.2.3. By Application
7.2.4. By End Use
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
7.4.1. Diagnosis
7.4.2. SPECT
7.4.3. PET
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
7.5.1. Urology
7.5.2. Cardiology
7.5.3. Neurology
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
7.6.1. Hospitals
7.6.2. Diagnostic Centres
7.7. Market Attractiveness Analysis
8. East Asia Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
8.2.1. By Country
8.2.2. By Product
8.2.3. By Application
8.2.4. By End Use
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
8.4.1. Diagnosis
8.4.2. SPECT
8.4.3. PET
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
8.5.1. Urology
8.5.2. Cardiology
8.5.3. Neurology
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
8.6.1. Hospitals
8.6.2. Diagnostic Centres
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
9.2.1. By Country
9.2.2. By Product
9.2.3. By Application
9.2.4. By End Use
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
9.4.1. Diagnosis
9.4.2. SPECT
9.4.3. PET
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
9.5.1. Urology
9.5.2. Cardiology
9.5.3. Neurology
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
9.6.1. Hospitals
9.6.2. Diagnostic Centres
9.7. Market Attractiveness Analysis
10. Latin America Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
10.2.1. By Country
10.2.2. By Product
10.2.3. By Application
10.2.4. By End Use
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
10.4.1. Diagnosis
10.4.2. SPECT
10.4.3. PET
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
10.5.1. Urology
10.5.2. Cardiology
10.5.3. Neurology
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
10.6.1. Hospitals
10.6.2. Diagnostic Centres
10.7. Market Attractiveness Analysis
11. Middle East & Africa Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
11.2.1. By Country
11.2.2. By Product
11.2.3. By Application
11.2.4. By End Use
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
11.4.1. Diagnosis
11.4.2. SPECT
11.4.3. PET
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
11.5.1. Urology
11.5.2. Cardiology
11.5.3. Neurology
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
11.6.1. Hospitals
11.6.2. Diagnostic Centres
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. GE Healthcare
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Jubilant Life Sciences Ltd
12.3.3. Nordion (Canada), Inc.
12.3.4. Bracco Imaging S.P.A
12.3.5. The institute for radioelements (IRE)
12.3.6. NTP Radioisotopes SOC Ltd.
12.3.7. The Australian Nuclear Science and Technology Organization
12.3.8. Eczac?ba??-Monrol
12.3.9. Lantheus Medical Imaging, Inc
12.3.10. Eckert & Ziegler
12.3.11. Mallinckrodt
12.3.12. Cardinal Health
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations